Aveanna Healthcare Holdings Inc. Form 8-K Summary
Business Context and Reporting Period
Aveanna Healthcare Holdings Inc. filed a Form 8-K dated March 28, 2022, under Items 2.02 and 7.01. The filing announces that the company issued financial results for the three-month period and fiscal year ended January 1, 2022.
The filing identifies Aveanna as a Delaware corporation headquartered in Atlanta, Georgia, with common stock traded on Nasdaq under the symbol AVAH.
Financial Metrics
The filing text provided does not include the underlying press release or clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Changes Versus Prior Comparable Period
The filing text does not provide comparative financial results or a clear description of changes versus the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the filing text provided. These matters may appear in Exhibit 99.1, which is referenced but not included in the supplied content.
The information under Items 2.02 and 7.01, including Exhibit 99.1, is furnished rather than filed for purposes of Section 18 of the Exchange Act, except where specifically incorporated by reference in another filing.
Key Facts to Verify
- Obtain and review Exhibit 99.1, the March 28, 2022 press release announcing results for the three months and fiscal year ended January 1, 2022.
- Verify reported revenue, profitability, cash flow, margins, debt, liquidity, and any non-GAAP measures in the press release.
- Compare the reported results with the prior-year period and any guidance or outlook provided by management.
- Review disclosed risks, contingencies, unusual items, and adjustments accompanying the financial results.